Intel lawsuit spotlights board oversight
A shareholder lawsuit alleges Intel’s board mishandled approval of a 10% equity grant to the U.S. government — thrusting board processes and shareholder protection into the spotlight. The case raises fresh questions about documenting rationale, independent fairness opinions, and how audit and nom/gov committees vet politically sensitive or non‑standard deals reported.
Shareholder Richard Paisner (dandodiary.com) filed a Verified Stockholder Derivative Complaint in Delaware’s Court of Chancery on March 5, 2026 alleging fiduciary breaches tied to Intel’s August 2025 government-equity transaction. (news.bloomberglaw.com) The complaint alleges the deal effectively transferred roughly $11 billion of Intel stock to the U.S. government “for no meaningful consideration” and contends the transaction was approved under pressure from federal officials. (dandodiary.com) Intel’s announcement said the government would purchase 433.3 million shares at $20.47 per share (about $8.9 billion) to take a roughly 9.9% stake. (newsroom.intel.com) Court filings highlighted a different valuation footing, noting Intel “allocated $5.81 per share for the 275,000,000 shares” issued to the Department of Commerce while the market traded near $24.80, a discrepancy central to the plaintiff’s challenge. (news.bloomberglaw.com) Exhibits to the complaint include a November 21, 2025 books‑and‑records (Section 220) demand by Paisner and Intel’s refusal, raising scrutiny over what internal committee reviews—particularly the Audit & Finance Committee—documented about valuation and funding sources. (dandodiary.com) The filings flag process gaps plaintiffs say are the kind fairness opinions or a special committee would address, and legal commentary notes independent fairness analyses are commonly used to defend boards against exactly these pricing-and-process claims. (wyrick.com) Bloomberg Law and D&O Diary show the complaint names CEO Lip‑Bu Tan and Commerce Secretary Howard Lutnick as defendants and seeks monetary relief and unwinding of the August 2025 agreement, setting a litigation timetable that will probe board minutes, advisor engagement and any conflict declarations. (news.bloomberglaw.com) Intel’s public disclosures also stated the U.S. government would not receive a board seat under the deal and noted that roughly $5.7 billion of the funding came from previously awarded CHIPS Act grants. (newsroom.intel.com)
